Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JORGE TOMAS CASO

Allopathic & Osteopathic Physicians Family Medicine

NPI
1457308157
CMS profile
201338
Location
MIAMI, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$11.57

1 record · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $11.57 1

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $11.57 1

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JORGE TOMAS CASO

NPI 1457308157 · CMS profile ID 201338

Allopathic & Osteopathic Physicians / Family Medicine

MIAMI, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1457308157?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JORGE TOMAS CASO, NPI 1457308157, CMS profile ID 201338. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1457308157?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). JORGE TOMAS CASO, NPI 1457308157, CMS profile ID 201338. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1457308157?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
JORGE TOMAS CASO, NPI 1457308157, CMS profile ID 201338, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1457308157?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

1 matching record · $11.57 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 1 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–1 of 1.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $11.5709/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738478165 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $11.57 1
PY2022 $1,200.00 1
PY2023 $4,459.41 20
PY2024 $1,274.65 11
PY2025 $35.85 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2020, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2020 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $5,513,175.40 309
PY2024 Recipient $2,105.91 13
PY2024 Principal investigator $5,484,672.89 220
PY2023 Recipient $1,815.05 10
PY2023 Principal investigator $6,619,562.71 1,445
PY2022 Principal investigator $4,761,350.73 1,335
PY2021 Principal investigator $244,385.00 24
PY2019 Principal investigator $19,780.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

1,335 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $66,238.57 12/31/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES
A Phase 3 Randomized, Double-blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly with Influenza Vaccine in Adults 50 Years of Age or Older No dispute reported 06/30/2026 940396251
Principal investigator 1 Merck Sharp & Dohme LLC $1,959.39 12/31/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES
A Phase 3 Randomized, Double-blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly with Influenza Vaccine in Adults 50 Years of Age or Older No dispute reported 06/30/2026 940396257
Principal investigator 1 SANOFI PASTEUR INC. $4,433.62 12/29/2022 Non-covered Recipient Entity
Suncoast Research Associates LLC
A Parallel-group, Phase I/II, Randomized, Modified Double-blind, 3-arm, Active Comparator, Multi-center, Prevention Study to Evaluate the Immunogenicity and Safety of Two Adjuvanted Dose Levels of Panblok H7+MF59 Influenza Vaccine Compared With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older No dispute reported 06/30/2026 935556405
Principal investigator 1 ModernaTX, Inc. $237,928.73 12/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681331
Principal investigator 1 Janssen Pharmaceuticals, Inc $1,041.00 12/16/2022 Non-covered Recipient Entity
Suncoast Rsrch Associates Llc
A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older No dispute reported 06/30/2026 885215277
Principal investigator 1 Janssen Research & Development, LLC $9,900.00 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251483
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661623
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661625
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661627
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661629
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661631
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661633
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661635
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661637
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661639
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661641
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661643
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661645
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661647
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661649
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661651
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661653
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661655
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661657
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661659
Principal investigator 1 ModernaTX, Inc. $2,402.41 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661661
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661663
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661665
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661667
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661669
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661671
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661673
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661675
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661677
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661679
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661681
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661683
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661685
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661687
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661689
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661691
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661693
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661695
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661697
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661699
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661701
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661703
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661705
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661707
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661709
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661711
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661713
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661715
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661717
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661719
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661721
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661723
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661725
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661727
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661729
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661731
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661733
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661735
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661737
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661739
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661741
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661743
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661745
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661747
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661749
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661751
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661753
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661755
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661757
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661759
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661761
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661763
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661765
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661767
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661769
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661771
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661773
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661775
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661777
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661779
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661781
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661783
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661785
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661787
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661789
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661791
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661793
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661795
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661797
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661799
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661801
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661803
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661805
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661807
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661809
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661811
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661813
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661815
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661817
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661819
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661821
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661823
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661825
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661827
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661829
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661831
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661833
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661835
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661837
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661839
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661841
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661843
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661845
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661847
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661849
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661851
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661853
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661855
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661857
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661859
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661861
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661863
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661867
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661869
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661871
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661873
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661875
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661877
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661879
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661881
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661883
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661885
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661887
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661889
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661891
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661893
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661895
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661897
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661899
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661901
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661903
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661905
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661907
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661909
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661911
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661913
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661915
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661917
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661919
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661921
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661923
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661925
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661927
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661929
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661931
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661933
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661935
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661937
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661939
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661941
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661943
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661945
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661947
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661949
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661951
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661953
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661955
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661957
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661959
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661961
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661963
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661965
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661967
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661969
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661971
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661973
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661975
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661977
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661979
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661981
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661983
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661985
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661987
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661989
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661991
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661993
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661995
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661997
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661999
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662001
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662003
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662005
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662007
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662009
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662011
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662013
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662015
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662017
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662019
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662021
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662023
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662025
Principal investigator 1 ModernaTX, Inc. $1,990.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662027
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662029
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662031
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662033
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662035
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662037
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662039
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662041
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662043
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662045
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662047
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662049
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662051
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662053
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662055
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662057
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662059
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662061
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662063
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662065
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662067
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662069
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662071
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662073
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662075
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662077
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662079
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662081
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662083
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662085
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662087
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662089
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662091
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662093
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662095
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662097
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662099
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662101
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662103
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662105
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662107
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662109
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662111
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662113
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662115
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662117
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662119
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662121
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662123
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662125
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662127
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662129
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662131
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662133
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662135
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662137
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662139
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662141
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662143
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662145
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662147
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662149
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662151
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662153
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662155
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662157
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662159
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662161
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662163
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662165
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662167
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662169
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662171
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662173
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662175
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662177
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662179
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662181
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662183
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662185
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662187
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662189
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662191
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662193
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662195
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662197
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662199
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662201
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662203
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662205
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662207
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662209
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662211
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662213
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662215
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662217
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662219
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662221
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662223
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662225
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662227
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662229
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662231
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662233
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662235
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662237
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662239
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662241
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662243
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662245
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662247
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662249
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662251
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662253
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662255
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662257
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662259
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662261
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662263
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662265
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662267
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662269
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662271
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662273
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662275
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662277
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662279
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662281
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662283
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662285
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662287
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662289
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662291
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662293
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662295
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662297
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662299
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662301
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662303
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662305
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662307
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662309
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662311
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662313
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662315
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662317
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662319
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662321
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662323
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662325
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662327
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662329
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662331
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662333
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662335
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662337
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662339
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662341
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662343
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662345
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662347
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662349
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662351
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662353
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662355
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662357
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662359
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662361
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662363
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662365
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662367
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662369
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662371
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662373
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662375
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662377
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662379
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662381
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662383
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662385
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662387
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662389
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662391
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662393
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662395
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662397
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662399
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662401
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662403
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662405
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662407
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662409
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662411
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662413
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662415
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662417
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662419
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662421
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662423
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662425
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662427
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662429
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662431
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662433
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662435
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662437
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662439
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662441
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662443
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662445
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662447
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662449
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662451
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662453
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662455
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662457
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662459
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662461
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662463
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662465
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662467
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662469
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662471
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662473
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662475
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662477
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662479
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662481
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662483
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662485
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662487
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662489
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662491
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662493
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662495
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662497
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662499
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662501
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662503
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662505
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662507
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662509
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662511
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662513
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662515
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662517
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662519
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662521
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662523
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662525
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662527
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662529
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662531
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662533
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662535
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662537
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662539
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662541
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662543
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662545
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662547
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662549
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662551
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662553
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662555
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662557
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662559
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662561
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662563
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662565
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662567
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662569
Principal investigator 1 ModernaTX, Inc. $1,990.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662571
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662573
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662575
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662577
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662579
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662581
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662583
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662585
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662587
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662589
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662591
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662593
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662595
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662597
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662599
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662601
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662603
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662605
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662607
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662609
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662611
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662613
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662615
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662617
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662619
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662621
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662623
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662625
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662627
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662629
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662631
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662633
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662635
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662637
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662639
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662641
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662643
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662645
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662647
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662649
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662651
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662653
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662655
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662657
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662659
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662661
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662663
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662665
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662667
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662669
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662671
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662673
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662675
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662677
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662679
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662681
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662683
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662685
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662687
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662689
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662691
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662693
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662695
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662697
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662699
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662701
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662703
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662705
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662707
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662709
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662711
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662713
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662715
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662717
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662719
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662721
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662723
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662727
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662729
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662731
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662733
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662735
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662737
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662739
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662741
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662743
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662745
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662747
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662749
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662751
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662753
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662755
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662757
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662759
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662761
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662763
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662765
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662767
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662769
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662771
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662773
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662775
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662777
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662779
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662781
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662783
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662785
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662787
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662789
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662791
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662793
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662795
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662797
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662799
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662801
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662803
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662805
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662807
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662809
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662811
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662813
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662815
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662817
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662819
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662821
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662823
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662825
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662827
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662829
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662831
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662833
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662835
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662837
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662839
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662841
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662843
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662845
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662847
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662849
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662851
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662853
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662855
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662857
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662859
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662861
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662863
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662865
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662867
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662869
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662871
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662873
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662875
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662877
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662879
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662881
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662883
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662885
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662887
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662889
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662891
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662893
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662895
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662897
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662899
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662901
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662903
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662905
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662907
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662909
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662911
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662913
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662915
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662917
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662919
Principal investigator 1 ModernaTX, Inc. $2,402.41 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662921
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662923
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662925
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662927
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662929
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662931
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662933
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662935
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662937
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662939
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662941
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662943
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662945
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662947
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662949
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662951
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662953
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662955
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662957
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662959
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662961
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662963
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662965
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662967
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662969
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662971
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662973
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662975
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662977
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662979
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662981
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662983
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662985
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662987
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662989
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662991
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662993
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662995
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662997
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963662999
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663001
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663003
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663005
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663007
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663009
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663011
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663013
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663015
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663017
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663019
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663021
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663023
Principal investigator 1 ModernaTX, Inc. $1,990.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663025
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663027
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663029
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663031
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663033
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663035
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663037
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663039
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663041
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663043
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663045
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663047
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663049
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663051
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663053
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663055
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663057
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663059
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663061
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663063
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663065
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663067
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663069
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663071
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663073
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663075
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663077
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663079
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663081
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663083
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663085
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663087
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663089
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663091
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663093
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663095
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663097
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663099
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663101
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663103
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663105
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663107
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663109
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663111
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663113
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663115
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663117
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663119
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663121
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663123
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663125
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663127
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663129
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663131
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663133
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663135
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663137
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663139
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663141
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663143
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663145
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663147
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663149
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663151
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663153
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663155
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663157
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663159
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663161
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663163
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663165
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663167
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663169
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663171
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663173
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663175
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663177
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663179
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663181
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663183
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663185
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663187
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663189
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663191
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663193
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663195
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663197
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663199
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663201
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663203
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663205
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663207
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663209
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663211
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663213
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663215
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663217
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663219
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663221
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663223
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663225
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663227
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663229
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663231
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663233
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663235
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663237
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663239
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663241
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663243
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663245
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663247
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663249
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663251
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663253
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663255
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663257
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663259
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663261
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663263
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663265
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663267
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663269
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663271
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663273
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663275
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663277
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663279
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663281
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663283
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663285
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663287
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663289
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663291
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663293
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663295
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663297
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663299
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663301
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663303
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663305
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663307
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663309
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663311
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663313
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663315
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663317
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663319
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663321
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663323
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663325
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663327
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663329
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663331
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663333
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663335
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663337
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663339
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663341
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663343
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663345
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663347
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663349
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663351
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663353
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663355
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663357
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663359
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663361
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663363
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663365
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663367
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663369
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663371
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663373
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663375
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663377
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663379
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663381
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663383
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663385
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663387
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663389
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663391
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663393
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663395
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663397
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663399
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663401
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663403
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663405
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663407
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663409
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663411
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663413
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663415
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663417
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663419
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663421
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663423
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663425
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663427
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663429
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663431
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663433
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663435
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663437
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663439
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663441
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663443
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663445
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663447
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663449
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663451
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663453
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663455
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663457
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663459
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663463
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663465
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663467
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663469
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663471
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663473
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663475
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663477
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663479
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663481
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663483
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663485
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663487
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663489
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663491
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663493
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663495
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663497
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663499
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663501
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663503
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663505
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663507
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663509
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663511
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663513
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663515
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663517
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663519
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663521
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663523
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663525
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663527
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663529
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663531
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663533
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663535
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663537
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663539
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663541
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663543
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663545
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663547
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663549
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663551
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663553
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663555
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663557
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663559
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663561
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663563
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663565
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663567
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663569
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663571
Principal investigator 1 ModernaTX, Inc. $2,402.41 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663573
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663575
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663577
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663579
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663581
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663583
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663585
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663587
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663589
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663591
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663593
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663595
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663597
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663599
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663601
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663603
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663605
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663607
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663609
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663611
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663613
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663615
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663617
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663619
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663621
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663623
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663625
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663627
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663629
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663631
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663633
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663635
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663637
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663639
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663641
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663643
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663645
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663647
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663649
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663651
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663653
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663655
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663657
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663659
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663661
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663663
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663665
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663667
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663669
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663671
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663673
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663675
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663677
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663679
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663681
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663683
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663685
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663687
Principal investigator 1 ModernaTX, Inc. $1,990.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663689
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663691
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663693
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663695
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663697
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663699
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663701
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663703
Principal investigator 1 ModernaTX, Inc. $2,402.41 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663705
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663707
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663709
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663711
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663713
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663715
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663717
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663719
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663721
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663723
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663725
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663727
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663729
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663731
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663733
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663735
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663737
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663739
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663741
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663743
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663745
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663747
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663749
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663751
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663753
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663755
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663757
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663759
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663763
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663765
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663767
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663769
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663771
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663773
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663775
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663777
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663779
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663781
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663783
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663785
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663787
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663789
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663791
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663793
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663795
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663797
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663799
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663801
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663803
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663805
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663901
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663903
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663905
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663907
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663909
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663911
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663913
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663915
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663917
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663919
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663921
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663923
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663925
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663927
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663929
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663931
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663933
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663935
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663937
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663939
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663941
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663943
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663945
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663947
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663949
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663951
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663953
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663955
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663957
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663959
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663961
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663963
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663965
Principal investigator 1 ModernaTX, Inc. $544.06 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663967
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663969
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663971
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663973
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663975
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663977
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663979
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663981
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663983
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663985
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663987
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663989
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663991
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663993
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663995
Principal investigator 1 ModernaTX, Inc. $635.84 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663997
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663999
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963664001
Principal investigator 1 ModernaTX, Inc. $3,715.65 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963664003
Principal investigator 1 ModernaTX, Inc. $15.73 12/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963664005
Principal investigator 1 Emergent BioSolutions Inc. $141,224.66 12/14/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087369
Principal investigator 1 Merck Sharp & Dohme LLC $102,155.00 12/07/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Phase 3 Randomized, Double-blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly with Influenza Vaccine in Adults 50 Years of Age or Older No dispute reported 06/30/2026 940395861
Principal investigator 1 Janssen Pharmaceuticals, Inc $5,475.00 12/05/2022 Non-covered Recipient Entity
Suncoast Rsrch Associates Llc
A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older No dispute reported 06/30/2026 885215281
Principal investigator 1 ModernaTX, Inc. $2,000.00 12/05/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661865
Principal investigator 1 ModernaTX, Inc. $9,500.00 12/05/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963663761
Principal investigator 1 Janssen Research & Development, LLC $3,250.00 12/02/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251481
Principal investigator 1 Janssen Research & Development, LLC $780.00 12/02/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251485
Principal investigator 1 GlaxoSmithKline, LLC. $34,793.92 11/25/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE 1, SINGLE-BLIND, SAFETY, REACTOGENICITY, AND IMMUNOGENICITY TR No dispute reported 06/30/2026 943947969
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661403
Principal investigator 1 ModernaTX, Inc. $635.84 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661405
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661407
Principal investigator 1 ModernaTX, Inc. $3,715.65 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661409
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661411
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661413
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661415
Principal investigator 1 ModernaTX, Inc. $635.84 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661417
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661419
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661421
Principal investigator 1 ModernaTX, Inc. $635.84 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661423
Principal investigator 1 ModernaTX, Inc. $3,715.65 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661425
Principal investigator 1 ModernaTX, Inc. $3,715.65 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661427
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661429
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661431
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661433
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661435
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661437
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661439
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661441
Principal investigator 1 ModernaTX, Inc. $635.84 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661443
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661445
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661447
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661449
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661451
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661453
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661455
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661457
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661459
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661461
Principal investigator 1 ModernaTX, Inc. $3,715.65 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661463
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661465
Principal investigator 1 ModernaTX, Inc. $635.84 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661467
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661469
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661471
Principal investigator 1 ModernaTX, Inc. $635.84 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661473
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661475
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661477
Principal investigator 1 ModernaTX, Inc. $3,715.65 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661479
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661481
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661483
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661485
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661487
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661489
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661491
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661493
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661495
Principal investigator 1 ModernaTX, Inc. $635.84 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661497
Principal investigator 1 ModernaTX, Inc. $3,715.65 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661499
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661501
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661503
Principal investigator 1 ModernaTX, Inc. $544.06 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661505
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661507
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661509
Principal investigator 1 ModernaTX, Inc. $635.84 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661511
Principal investigator 1 ModernaTX, Inc. $635.84 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661513
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661515
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661517
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661519
Principal investigator 1 ModernaTX, Inc. $3,715.65 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661521
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661523
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661525
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661527
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661529
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661531
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661533
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661535
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661537
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661539
Principal investigator 1 ModernaTX, Inc. $3,715.65 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661541
Principal investigator 1 ModernaTX, Inc. $635.84 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661543
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661545
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661547
Principal investigator 1 ModernaTX, Inc. $3,715.65 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661549
Principal investigator 1 ModernaTX, Inc. $635.84 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661551
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661553
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661555
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661557
Principal investigator 1 ModernaTX, Inc. $3,715.65 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661603
Principal investigator 1 ModernaTX, Inc. $635.84 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661605
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661607
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661609
Principal investigator 1 ModernaTX, Inc. $635.84 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661611
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661613
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661615
Principal investigator 1 ModernaTX, Inc. $635.84 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661617
Principal investigator 1 ModernaTX, Inc. $15.73 11/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661619
Principal investigator 1 ModernaTX, Inc. $149,092.82 11/18/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681085
Principal investigator 1 ModernaTX, Inc. $29,220.48 11/14/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681267
Principal investigator 1 Emergent BioSolutions Inc. $95,602.94 11/09/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087173
Principal investigator 1 GlaxoSmithKline, LLC. $2,214.04 11/09/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 943947951
Principal investigator 1 ModernaTX, Inc. $14,125.00 11/09/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681265
Principal investigator 1 ModernaTX, Inc. $120,471.02 11/02/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681083
Principal investigator 1 ModernaTX, Inc. $8,162.12 11/02/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681259
Principal investigator 1 ModernaTX, Inc. $360.53 11/02/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681261
Principal investigator 1 ModernaTX, Inc. $650.00 11/02/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681263
Principal investigator 1 Janssen Research & Development, LLC $13,300.00 10/31/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251473
Principal investigator 1 ModernaTX, Inc. $47,349.05 10/26/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681063
Principal investigator 1 ModernaTX, Inc. $175.00 10/19/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681075
Principal investigator 1 ModernaTX, Inc. $1,750.00 10/19/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681077
Principal investigator 1 ModernaTX, Inc. $1,050.00 10/19/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681079
Principal investigator 1 ModernaTX, Inc. $375.00 10/19/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681081
Principal investigator 1 Janssen Research & Development, LLC $5,980.00 10/17/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251475
Principal investigator 1 Janssen Research & Development, LLC $6,261.00 10/17/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251479
Principal investigator 1 ModernaTX, Inc. $114,386.75 10/14/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681059
Principal investigator 1 ModernaTX, Inc. $78,442.83 10/14/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681061
Principal investigator 1 Emergent BioSolutions Inc. $60,227.20 10/12/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087225
Principal investigator 1 ModernaTX, Inc. $9,319.11 10/12/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681065
Principal investigator 1 ModernaTX, Inc. $1,400.00 10/12/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681067
Principal investigator 1 ModernaTX, Inc. $5,863.02 10/12/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681069
Principal investigator 1 ModernaTX, Inc. $2,250.00 10/12/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681071
Principal investigator 1 ModernaTX, Inc. $721.05 10/12/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults 50 Years of Age No dispute reported 06/30/2026 963681073
Principal investigator 1 Janssen Research & Development, LLC $83,300.00 10/10/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251477
Principal investigator 1 ModernaTX, Inc. $18.00 10/06/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963661621
Principal investigator 1 Emergent BioSolutions Inc. $16,011.00 10/05/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087837
Principal investigator 1 Emergent BioSolutions Inc. $20,314.94 10/05/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087849
Principal investigator 1 Janssen Research & Development, LLC $6,253.00 09/23/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251471
Principal investigator 1 ModernaTX, Inc. $6,360.00 09/16/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH GROUP LLC
A PHASE 3, RANDOMIZED, OBSERVER-BLIND, ACTIVE-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MRNA-1010 CANDIDATE SEASONAL INFLUENZA VACCINE IN ADULTS 50 YEARS AND OLDER No dispute reported 06/30/2026 963224449
Principal investigator 1 Emergent BioSolutions Inc. $312,141.00 09/14/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087857
Principal investigator 1 Emergent BioSolutions Inc. $10,669.00 09/14/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087905
Principal investigator 1 ModernaTX, Inc. $498.00 08/29/2022 Non-covered Recipient Entity
ELITE RESEARCH NETWORK
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older No dispute reported 06/30/2026 963566735
Principal investigator 1 Janssen Pharmaceuticals, Inc $1,621.00 08/26/2022 Non-covered Recipient Entity
Suncoast Rsrch Associates Llc
A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older No dispute reported 06/30/2026 885215273
Principal investigator 1 Emergent BioSolutions Inc. $13,000.00 08/24/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087429
Principal investigator 1 GlaxoSmithKline, LLC. $11,785.49 08/24/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE 1, SINGLE-BLIND, SAFETY, REACTOGENICITY, AND IMMUNOGENICITY TR No dispute reported 06/30/2026 943947955
Principal investigator 1 GlaxoSmithKline, LLC. $5,567.00 08/19/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE 1, SINGLE-BLIND, SAFETY, REACTOGENICITY, AND IMMUNOGENICITY TR No dispute reported 06/30/2026 943947953
Principal investigator 1 GlaxoSmithKline, LLC. $4,680.89 08/19/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 943947957
Principal investigator 1 GlaxoSmithKline, LLC. $1,860.42 08/19/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE 1, SINGLE-BLIND, SAFETY, REACTOGENICITY, AND IMMUNOGENICITY TR No dispute reported 06/30/2026 943947961
Principal investigator 1 GlaxoSmithKline, LLC. $7,461.22 08/19/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 943947971
Principal investigator 1 Janssen Research & Development, LLC $11,193.00 08/19/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251469
Principal investigator 1 Emergent BioSolutions Inc. $23,965.00 08/17/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087175
Principal investigator 1 Emergent BioSolutions Inc. $11,097.84 08/17/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087579
Principal investigator 1 Emergent BioSolutions Inc. $35,561.06 08/10/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087121
Principal investigator 1 GlaxoSmithKline, LLC. $1,754.62 08/03/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE 1, SINGLE-BLIND, SAFETY, REACTOGENICITY, AND IMMUNOGENICITY TR No dispute reported 06/30/2026 943947947
Principal investigator 1 Janssen Pharmaceuticals, Inc $12,770.00 08/03/2022 Non-covered Recipient Entity
Suncoast Rsrch Associates Llc
A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older No dispute reported 06/30/2026 885215269
Principal investigator 1 Emergent BioSolutions Inc. $38,067.00 07/27/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087547
Principal investigator 1 Janssen Pharmaceuticals, Inc $80,073.00 07/22/2022 Non-covered Recipient Entity
Suncoast Rsrch Associates Llc
A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older No dispute reported 06/30/2026 885215265
Principal investigator 1 Emergent BioSolutions Inc. $24,525.00 07/20/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087585
Principal investigator 1 Emergent BioSolutions Inc. $1,761.00 07/20/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087805
Principal investigator 1 Emergent BioSolutions Inc. $451,775.00 07/13/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087239
Principal investigator 1 Janssen Research & Development, LLC $190,020.00 06/27/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251461
Principal investigator 1 Janssen Research & Development, LLC $1,520.00 06/27/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251465
Principal investigator 1 Janssen Research & Development, LLC $147.00 06/24/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251467
Principal investigator 1 GlaxoSmithKline, LLC. $8,724.62 06/22/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 943947963
Principal investigator 1 Alnylam Pharmaceuticals Inc. $100.00 06/08/2022 Non-covered Recipient Entity
Suncoast Research Associates LLC
A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH) No dispute reported 06/30/2026 910104941
Principal investigator 1 Alnylam Pharmaceuticals Inc. $89.00 06/08/2022 Non-covered Recipient Entity
Suncoast Research Associates LLC
A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH) No dispute reported 06/30/2026 910104947
Principal investigator 1 Alnylam Pharmaceuticals Inc. $82.00 06/08/2022 Non-covered Recipient Entity
Suncoast Research Associates LLC
A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH) No dispute reported 06/30/2026 910104953
Principal investigator 1 Alnylam Pharmaceuticals Inc. $186.00 06/08/2022 Non-covered Recipient Entity
Suncoast Research Associates LLC
A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH) No dispute reported 06/30/2026 910104959
Principal investigator 1 Janssen Research & Development, LLC $1,613.00 06/06/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251463
Principal investigator 1 Janssen Research & Development, LLC $390.00 05/30/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251459
Principal investigator 1 GlaxoSmithKline, LLC. $4,485.53 05/25/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 943947979
Principal investigator 1 Janssen Research & Development, LLC $4,950.00 04/29/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251453
Principal investigator 1 GlaxoSmithKline, LLC. $20,680.25 04/27/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 943947983
Principal investigator 1 Janssen Research & Development, LLC $13,707.00 04/18/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251455
Principal investigator 1 GlaxoSmithKline, LLC. $2,289.15 04/13/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 943947959
Principal investigator 1 GlaxoSmithKline, LLC. $2,289.15 04/13/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 943947967
Principal investigator 1 GlaxoSmithKline, LLC. $2,289.15 04/13/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 943947973
Principal investigator 1 GlaxoSmithKline, LLC. $8,593.70 04/13/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 943947977
Principal investigator 1 Janssen Research & Development, LLC $201,905.00 04/08/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251457
Principal investigator 1 Emergent BioSolutions Inc. $181,883.00 03/30/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087485
Principal investigator 1 GlaxoSmithKline, LLC. $25,941.29 03/25/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 943947975
Principal investigator 1 Emergent BioSolutions Inc. $5,418.75 03/23/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087417
Principal investigator 1 Janssen Research & Development, LLC $68,290.00 03/18/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251449
Principal investigator 1 Janssen Research & Development, LLC $75,280.00 03/18/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A Randomized, Double-blind Phase 3 Study to Assess the Immunogenicity and Safety of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65Years No dispute reported 06/30/2026 885251451
Principal investigator 1 SANOFI PASTEUR INC. $3,950.00 03/14/2022 Non-covered Recipient Entity
Suncoast Research Group,LLC
Immunogenicity and Safety of the First-in-Human SARS-CoV-2 mRNA Vaccine Formulation in Healthy Adults 18 Years of Age and Older No dispute reported 06/30/2026 935556447
Principal investigator 1 Alnylam Pharmaceuticals Inc. $4,457.40 03/11/2022 Non-covered Recipient Entity
Suncoast Research Associates LLC
A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH) No dispute reported 06/30/2026 910104757
Principal investigator 1 SANOFI PASTEUR INC. $14,840.00 03/07/2022 Non-covered Recipient Entity
Suncoast Research Associates LLC
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults Aged 50 to 84 Years No dispute reported 06/30/2026 935556325
Principal investigator 1 SANOFI PASTEUR INC. $1,180.00 03/07/2022 Non-covered Recipient Entity
Suncoast Research Group,LLC
Immunogenicity and Safety of the First-in-Human SARS-CoV-2 mRNA Vaccine Formulation in Healthy Adults 18 Years of Age and Older No dispute reported 06/30/2026 935556451
Principal investigator 1 SANOFI PASTEUR INC. $1,500.00 03/07/2022 Non-covered Recipient Entity
Suncoast Research Group,LLC
Immunogenicity and Safety of the First-in-Human SARS-CoV-2 mRNA Vaccine Formulation in Healthy Adults 18 Years of Age and Older No dispute reported 06/30/2026 935556457
Principal investigator 1 Emergent BioSolutions Inc. $55,281.00 03/02/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087889
Principal investigator 1 GlaxoSmithKline, LLC. $52,844.30 02/25/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 943947949
Principal investigator 1 GlaxoSmithKline, LLC. $6,325.84 02/25/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 965505071
Principal investigator 1 GlaxoSmithKline, LLC. $3,567.78 02/25/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 965505073
Principal investigator 1 Emergent BioSolutions Inc. $238,769.00 02/23/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087865
Principal investigator 1 SANOFI PASTEUR INC. $4,150.00 02/16/2022 Non-covered Recipient Entity
Suncoast Research Group,LLC
Immunogenicity and Safety of the First-in-Human SARS-CoV-2 mRNA Vaccine Formulation in Healthy Adults 18 Years of Age and Older No dispute reported 06/30/2026 935556441
Principal investigator 1 Emergent BioSolutions Inc. $6,318.75 02/02/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087045
Principal investigator 1 Emergent BioSolutions Inc. $1,806.25 02/02/2022 Non-covered Recipient Entity
Suncoast Research Associates, LLC
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 No dispute reported 06/30/2026 927087063
Principal investigator 1 GlaxoSmithKline, LLC. $251,401.80 01/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 943947965
Principal investigator 1 GlaxoSmithKline, LLC. $18,488.66 01/21/2022 Non-covered Recipient Entity
SUNCOAST RESEARCH ASSOCIATES LLC
A PHASE III, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTI-CENTER STUDY TO No dispute reported 06/30/2026 943947981
Principal investigator 1 SANOFI PASTEUR INC. $1,855.00 01/21/2022 Non-covered Recipient Entity
Suncoast Research Associates LLC
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults Aged 50 to 84 Years No dispute reported 06/30/2026 935556309
Principal investigator 1 SANOFI PASTEUR INC. $16,390.00 01/21/2022 Non-covered Recipient Entity
Suncoast Research Associates LLC
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults Aged 50 to 84 Years No dispute reported 06/30/2026 935556315